SAGE working group on conjugate pneumococcal vaccine (March 2006 to March 2007)
Terms of Reference
- To summarize existing evidence on the burden of pneumococcal disease in developing countries and the safety, immunogenicity, efficacy, and cost-effectiveness of pneumococcal conjugate vaccination in developing countries.
- To provide SAGE with summaries and analyses needed to support its discussion and recommendation process.
- To provide SAGE with a draft position statement for their review and approval, based on the data and the discussions and inputs of the SAGE membership.
Composition
SAGE Members
- Art Reingold
- Jose Ignacio Santos
Experts
- Tatu Kamau, Kenya Expanded Programme for Immunization (KEPI)
- Orin Levine, Johns Hopkins University, USA
- Kate O'Brien, Johns Hopkins University, USA
- Stephanie Schrag, Centers for Disease Control and Prevention, USA
WHO Secretariat
- Thomas Cherian
Last reviewed: 24 September 2009